Health Care Supplies

AUTEK

AUTEK released FY2026 Q1 earnings on April 22 Pre-Market (BJT), actual revenue CNY 459.45 M, actual EPS CNY 0.1637

AUTEK FY2026 Q1 Earnings Release on April 23 Pre-Market BJT

AUTEK released FY2025 Q4 earnings on March 27 After-Market (BJT), actual revenue CNY 428.36 M (forecast CNY 360.28 M), actual EPS CNY 0.0419 (forecast CNY 0.0959)

AUTEK released FY2025 annual earnings on March 27 After-Market (BJT), actual revenue CNY 1.861 B (forecast CNY 1.816 B), actual EPS CNY 0.537 (forecast CNY 0.5679)

AUTEK to release FY2025 earnings report on March 28 After-Market (BJT), forecast revenue CNY 1.817 B, EPS CNY 0.5679

AUTEK released FY2025 Q3 earnings on October 24 After-Market (BJT), actual revenue CNY 562.1 M (forecast CNY 599.24 M), actual EPS CNY 0.2165 (forecast CNY 0.2321)

AUTEK released FY2025 9 Months Earnings on October 24 After-Market BJT, actual revenue CNY 1.433 B, actual EPS CNY 0.4955

AUTEK to Release FY2025 Q3 Earnings on October 25 After-Market (BJT), Forecast Revenue CNY 599.24 M, EPS CNY 0.2321

AUTEK released FY2025 Q2 earnings on August 22 After-Market (BJT), actual revenue CNY 392.48 M (forecast CNY 458.08 M), actual EPS CNY 0.1001 (forecast CNY 0.1274)

AUTEK released FY2025 Semi-Annual Earnings on August 22 After-Market (BJT), with actual revenue of CNY 870.7 M and EPS of CNY 0.279

AUTEK FY2025 Semi-Annual Earnings Release on August 23, 2025 (BJT)

Optical Cross-Eye Vision Secretary Answers on Atropine Progress and Cross-border E-commerce Layout

OPKoncis Shareholders Count 63,178

Ophtec Subsidiary's Soft Hydrophilic Contact Lens Registration Application Accepted

Ophekon Visited Plans Acquisition of Shangyue Qi Cheng to Continue Expansion

Ophtec Announces Acquisition of 75% Equity in Shangyue Qi Cheng for 334 Million Yuan

Opcon Vision Plans to Acquire 75% Equity of Suqian Shangyue Qichen for 334 Million Yuan

Progress of Innovative Drug R&D by OPKO's Participated Companies

OPKangsheng Submits New Trademark Applications

OPCONSEYES New Rigid Lens Promotions Going Well

300595

AUTEK recently obtained the "Drug Manufacturing License" issued by the Anhui Provincial Drug Administration, valid until December 25, 2030. The company stated that this license will help optimize product structure and promote long-term development, but it will have little impact on operating performance in the short term. The company must complete product registration applications and related inspections before it can commence commercial production and sales. The production and sales of pharmaceutical products are affected by industry policies and market conditions, which carry uncertainties

36Kr

AUTEK: Obtained the "Drug Manufacturing License"

According to the Zhitong Finance APP, AUTEK released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 1.433 billion yuan, a year-on-year increase of 0.13%. The net profit attributable to shareholders of the listed company was 442 million yuan, a year-on-year decrease of 15.41%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 392 million yuan, a year-on-year decrease of 17.21%. The basic earnings per share were 0.495 yuan

Zhitong

AUTEK released its performance for the first three quarters, with a net profit attributable to the parent company of 442 million yuan, a decrease of 15.41%

A wholly-owned subsidiary of AUTEK, Jiangsu Duozi Medical Technology Co., Ltd., has obtained a Class III medical device registration certificate for its new product "soft hydrophilic contact lenses." This product is a daily-wear soft hydrophilic contact lens with a water content of 43%, recommended for a replacement cycle of one day, sterilized by moist heat, with a shelf life of 5 years, suitable for correcting myopia in patients without contraindications. The registration certificate number is 20253162076, valid until October 20, 2030

AUTEK: Soft hydrophilic contact lenses have obtained medical device registration certificates

According to the Zhitong Finance APP, AUTEK announced that the company recently received the "Medical Device Registration Certificate" issued by the Anhui Provincial Drug Administration, and the company's "Medical Ultrasonic Nebulizer" has completed registration and obtained the Class II Medical Device Registration Certificate

AUTEK has obtained a medical device registration certificate

AUTEK stated in an online meeting on August 25 that it expects to increase the number of controlled optical terminals by 30 by the first half of 2025, bringing the total to over 520. Due to the weakness in the high-end consumer medical market, the company is taking a cautious approach to the establishment of new optical terminals, emphasizing that implementation must have significant feasibility. At the same time, the company's investment focus has shifted to optical service institutions that already have a substantial business scale in the region and possess sustainable growth potential

AUTEK: The company holds a cautious attitude towards the newly established optometry terminals

On the online meeting held on August 25th, AUTEK stated that the promotion of the DK185 orthokeratology lens is going well, with users generally recognizing it, and the proportion of new products is gradually expanding. According to the orders received from headquarters, June was the first month of the product launch, with a share of approximately 0.6%, and the current share of new products has reached 7%

AUTEK: The promotion of DK185 orthokeratology lenses is going well, and the proportion of new products is gradually increasing

688247

002657

On August 25th, a total of 6 listed companies had their restricted shares unlocked, with a total market value of approximately 3.883 billion yuan. The specific situation of the restricted shares unlocked today is as follows: Stock Abbreviation Stock Code Restricted Share Type Unlocked Shares Zhongke Jincai 002657 Equity Incentive Restricted Circulation 1.2562 million AUTEK 300595 Equity Incentive Restricted Circulation 525,300 United Chemical 301209 Pre-issue Shares Restricted Circulation 55.5 million SINOTHERAPEUTICS 688247 3.11 billion DiAo Wei 688381 800 million Wantai Lingwei 688591 240 million

SINOTHERAPEUTICS

SINODATA

Zhitong A-share lock-up release overview | August 25

According to the Zhitong Finance APP, AUTEK released its semi-annual report for 2025, showing that the company's operating revenue was 871 million yuan, a year-on-year decrease of 1.42%. The net profit attributable to shareholders of the listed company was 250 million yuan, a year-on-year decrease of 22.93%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 216 million yuan, a year-on-year decrease of 23.60%. The basic earnings per share were 0.279 yuan

AUTEK released its performance for the first half of the year, with a net profit attributable to the parent company of 250 million yuan, a decrease of 22.93%

According to the Qichacha APP, recently, Jiangsu Leo Huiding Intelligent Technology Co., Ltd. was established, with Jiao Feihong as the legal representative. The business scope includes: development of basic software for artificial intelligence; sales of artificial intelligence hardware; development of application software for artificial intelligence; basic resources and technology platform for artificial intelligence, etc. Qichacha's equity penetration shows that the company is jointly held by RTX, AUTEK's wholly-owned subsidiary AUTEK Investment Co., Ltd., and others

RTX, AUTEK and others establish a new company, including multiple AI businesses

301038

002670

36Kr learned that the three major A-share indices collectively rose during the midday break, with the Shanghai Composite Index up 0.75%, the Shenzhen Component Index up 0.31%, and the ChiNext Index up 0.72%; new stocks N Shanda Power rose over 397%, and N Jiyuan rose over 302%; the large financial, water conservancy and hydropower, and medical sectors led the gains, with Guosheng Finance and SWPD hitting the daily limit, AUTEK rising over 17%, and China Pacific Insurance rising over 3%; the engineering machinery, aerospace and military, and building materials sectors saw the largest declines, with Guanglian Aviation down over 13%, Fujian Cement down over 7%, and Shantui down over 5%

SWPD

GUOSHENG SECURITIES

The three major A-share indices collectively rose at midday, with large financial stocks rallying

AUTEK(300595.SZ)